Clinical Trial Update: A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for a live intranasal Bordetella pertussis vaccine (GamLPV) investigating protection against whooping cough.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis
• Whooping Cough

Drugs mentioned

• GamLPV (Gamaleya live intranasal Bordetella pertussis vaccine)

Snippet

Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Conditions: Whooping Cough | Phase 1, Phase 2 | Status: UNKNOWN